The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

You can do a lot to take care of yourself and give your body what it needs. Still, as you get older, your body changes in ways you can't always control. For most men, one of those changes is that ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

While BPH isn't cancerous, according to the Cleveland Clinic, the symptoms of an enlarged prostate are often distressing. Let's explore the medications available to alleviate the symptoms.

VIJAYAWADA: Prashanth Hospital in Vijayawada introduced Resume Water Vapour Therapy for prostate problems, a first in the ...

Even though the parameters that would modify patient's adherence are multiple and complex (spanning from awareness campaigns to better patient counselling) it seems reasonable to support the use ...

Treatment with vibegron reduced the average number of micturition episodes per day and the average number of daily urgency episodes compared with placebo. The Food and Drug Administration (FDA ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.